RIPK1 and Alzheimer disease: TNF-α signaling modulates neuronal necroptosis in AD through the RIPK1/3 pathway and autophagy machinery. Targeting TNF-α/TNFR1 or UVRAG could be potential therapeutic strategies for AD.